Marko S. Zatylny


  • JD, Harvard Law School, 2002
  • BS (Accounting), magna cum laude, Brigham Young University, 1998


  • Massachusetts, 2002

Marko S. Zatylny


Marko focuses his practice on advising public and private companies, investment banks and investment funds in mergers & acquisitions, capital markets transactions and corporate governance issues. He handles transactions for clients in a number of industries, including life sciences, financial services, energy/cleantech and retail and consumer. His clients include companies such as Becton Dickinson, Domino’s Pizza, Keurig Green Mountain, LPL Financial, Novavax and Wright Medical Technology. Marko is co-chair of the firm’s energy/cleantech practice. In February 2015, Marko was named “Deal Maker of the Week” by The American Lawyer.


  • Pfizer in its pending acquisition of Hospira for approximately $17 billion.
  • Wright Medical in its pending merger of equals with Tornier NV
  • Novavax in its cross-border tender offer for the outstanding shares of Isconova, a Sweden-based publicly traded vaccine adjuvant company.
  • Wright Medical in its sale of its OrthoRecon business to Hong Kong-based MicroPort Scientific Corporation.
  • Becton Dickinson, a global medical technology company, in a number of divestitures and acquisitions
  • Pfizer in its acquisition of Excaliard Pharmaceuticals, a biopharmaceutical company focused on the development of novel drugs for the treatment of skin scarring.
  • The lead underwriters in the initial public offering of Cerulean Pharma Inc.
  • The lead underwriters in the follow-on offering of Insmed Incorporated.
  • The lead underwriters in the initial public offering and subsequent follow-on offerings of Bloomin’ Brands, Inc., one of the largest casual dining restaurant companies in the world.
  • LPL Financial Holdings, the holding company for one of the largest brokerage firms in the U.S., in its $522 million initial public offering and subsequent follow on offerings.
  • Represented clients in acquisitions of energy/utility assets and the negotiation of various power and energy contracts, including in the renewable energy sector.





  • Panelist, "From the Boardroom: Considerations in Option to Purchase Deals," Ropes & Gray Life Sciences Roundtable, San Francisco, January 12, 2014